Medicine & Health Sciences

Cancer Cell Signaling
Targeting Signaling Pathways Towards Therapeutic Approaches to Cancer

Editor: Kasirajan Ayyanathan, PhD

Cancer Cell Signaling

Published. Available now.
Pub Date: July 1, 2014
Hardback Price: $169.95 US
Hard ISBN: 9781771880671
E-Book ISBN: 9781482299458
Pages: 410pp
Binding Type: hardbound

This title includes a number of Open Access chapters.

The topic of cell signaling is a field that studies how cells communicate to control basic activities and respond to their environment. When looking specifically at cancer cells, researchers can gain a better understanding of cancer on a cellular level, an understanding that may have implications for developing new treatments. The current volume provides an overview of the field and how various cell biology techniques are used to better understand cancer on a cellular level.

This easily accessible reference volume offers a comprehensive look at the field of cancer cell signaling. Edited by a researcher from Florida Atlantic University, Cancer Cell Signaling: Targeting Signaling Pathways Towards Therapeutic Approaches to Cancer is an authoritative and easy-to-use reference.

Chapter 1. TGFβ-Mediated Suppression of CD248 in Non-Cancer Cells Via Canonical SMAD-Dependent Signaling Pathways Is Uncoupled in Cancer Cells
Sahana Suresh Babu, Yanet Valdez, Andrea Xu, Alice M. O’Byrne, Fernando Calvo,Victor Lei, and Edward M. Conway
Chapter 2. Graded Inhibition of Oncogenic Ras-signaling by Multivalent Ras-Binding Domains
Martin Augsten, Anika Böttcher, Rainer Spanbroek, Ignacio Rubio, and Karlheinz Friedrich
Chapter 3. Direct Inhibition of PI3K in Combination with Dual HER2 Inhibitors Is Required for Optimal Antitumor Activity in HER2+ Breast Cancer Cells
Brent N. Rexer, Siprachanh Chanthaphaychith, Kimberly Brown Dahlman, and Carlos L. Arteaga
Chapter 4. Wnt3a Expression Is Associated with MMP-9 Expression in Primary Tumor and Metastatic Site in Recurrent or Stage IV Colorectal Cancer
Myung Ah Lee, Jin-Hee Park, Si Young Rhyu, Seong-Taek Oh, Won-Kyoung Kang, and Hee-Na Kim
Chapter 5. Wnt5a Promotes Migration of Human Osteosarcoma Cells by Triggering a Phosphatidylinositol-3 Kinase/Akt Signals
Ailiang Zhang, Shuanghua He, Xiaoliang Sun, Lianghua Ding, Xinnan Bao, and Neng Wang
Chapter 6. FOXA1 Promotes Tumor Cell Proliferation Through AR Involving the Notch Pathway in Endometrial Cancer
Meiting Qiu, Wei Bao, Jingyun Wang, Tingting Yang, Xiaoying He, Yun Liao, and Xiaoping Wan
Chapter 7. PKC α Regulates Netrin-1/UNC5B-Mediated Survival Pathway in Bladder Cancer
Jiao Liu, Chui-ze Kong, Da-xin Gong, Zhe Zhang, and Yu-yan Zhu
Chapter 8. Signaling Pathways in the Development of Infantile Hemangioma
Yi Ji, Siyuan Chen, Kai Li, Li Li, Chang Xu, and Bo Xiang
Chapter 9. STAG2 Is a Clinically Relevant Tumor Suppressor in Pancreatic Ductal Adenocarcinoma
Lisa Evers, Pedro A. Perez-Mancera, Elizabeth Lenkiewicz, Nanyun Tang, Daniela Aust, Thomas Knösel, Petra Ru ümmele, Tara Holley, Michelle Kassner, Meraj Aziz, Ramesh K. Ramanathan, Daniel D. Von Hoff, Holly Yin, Christian Pilarsky, and Michael T. Barrett
Chapter 10. Molecular Determinants of Context-Dependent Progesterone Receptor Action in Breast Cancer
Christy R. Hagan and Carol A. Lange
Chapter 11. Architecture of Epigenetic Reprogramming Following Twist1-Mediated Epithelial-Mesenchymal Transition
Gabriel G. Malouf, Joseph H. Taube, Yue Lu, Tapasree Roysarkar, Shoghag Panjarian, Marcos R.H. Estecio, Jaroslav Jelinek, Jumpei Yamazaki, Noel J-M Raynal, Hai Long, Tomomitsu Tahara, Agata Tinnirello, Priyanka Ramachandran, Xiu-Ying Zhang, Shoudan Liang, Sendurai A. Mani, and Jean-Pierre J. Issa
Chapter 12. Stability and Prognostic Value of Slug, Sox9 and Sox10 Expression in Breast Cancers Treated with Neoadjuvant Chemotherapy
Cosima Riemenschnitter, Ivett Teleki, Verena Tischler, Wenjun Guo, and Zsuzsanna Varga
Chapter 13. Combination Therapy of Anti-Cancer Bioactive Peptide with Cisplatin Decreases Chemotherapy Dosing and Toxicity to Improve the Quality of Life in Xenograft Nude Mice Bearing Human Gastric Cancer
Xiulan Su, Chao Dong, Jialing Zhang, Liya Su, Xuemei Wang, Hongwei Cui, and Zhong Chen
Chapter 14. Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Kasirajan Ayyanathan, Shailaja Kesaraju, Ken Dawson-Scully, and Herbert Weissbach


About the Authors / Editors:
Editor: Kasirajan Ayyanathan, PhD
Research Associate Professor, Center for Molecular Biology and Biotechnology, Florida Atlantic University, Boca Raton, Florida

Kasirajan Ayyanathan, PhD, received his PhD degree from the Department of Biochemistry, Indian Institute of Science, one of the premier research institutions in India. Subsequently, at Temple University School of Medicine, Philadelphia, Pennsylvania, USA, he conducted post-doctoral research on the signal transduction by purinergic receptors, a class of G-Protein Coupled Receptors (GPCR), in erythroleukemia cancer cells. Next, he was trained as a staff scientist at the Wistar Institute, Philadelphia, for almost ten years and studied transcription regulation, chromatin, and epigenetic regulatory mechanisms in cancer before becoming an Associate Professor at Florida Atlantic University (FAU). He is a Research Associate Professor at the Center for Molecular Biology and Biotechnology. Presently, he is a visiting scholar at the Wistar Institute.

He is the recipient of Chern Memorial Award, presented by the Wistar Institute, and Howard Temin Career Research Award, presented by the National Cancer Institute, USA.Dr. Ayyanathan is well trained in molecular biology, cell biology, and biochemistry with main focus on studying transcription factors and gene regulation. He has contributed to several projects such as on the generation of conditional transcriptional repressors that are directed against the endogenous oncogenes to inhibit malignant growth, on the establishment of stable cell lines that express chromatin integrated transcriptional repressors and reporter genes in order to study the epigenetic mechanisms of KRAB repression, and on identification of novel SNAG repression domain interacting proteins in order to understand their roles in transcriptional repression and oncogenesis. Dr. Ayyanathan has published several research articles in peer-reviewed articles in these subject areas.

Follow us for the latest from Apple Academic Press:
Copyright © 2018 Apple Academic Press Inc. All Rights Reserved.